Literature DB >> 8258759

Entangled epidemics: cocaine use and HIV disease.

E P Larrat1, S Zierler.   

Abstract

Over the past decade, two epidemics have had a severe impact on public health in this country. These health problems involve cocaine abuse and AIDS (or HIV disease). The processes of these two conditions are clearly not independent of each other and may be quite complex. Understanding of this relationship has been hampered by a myriad of social, biological and behavioral variables that are entangled with the basic cocaine-HIV association. This article presents a paradigm for discussion of the interaction between cocaine exposure and HIV disease based on three mechanisms: the relationship between cocaine exposure and increased opportunity for HIV exposure, the direct role that cocaine plays in altering susceptibility to HIV infection, and the influence that cocaine use has on the progression of HIV disease. The goal of this structured approach is to enhance conceptual understanding of the cocaine-HIV relationship while recognizing the complexity of the issue and the limitations of current research efforts. This model will serve as a framework for the discussion of implications for future research, clinical practice, and public policy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8258759     DOI: 10.1080/02791072.1993.10472272

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  23 in total

Review 1.  Cocaine and HIV-1 interplay in CNS: cellular and molecular mechanisms.

Authors:  Shilpa Buch; Honghong Yao; Minglei Guo; Tomohisa Mori; Blaise Mathias-Costa; Vijeta Singh; Pankaj Seth; John Wang; Tsung-Ping Su
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

Review 2.  Rodent models of HAND and drug abuse: exogenous administration of viral protein(s) and cocaine.

Authors:  Honghong Yao; Shilpa Buch
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-24       Impact factor: 4.147

3.  Role of Sigma Receptor in Cocaine-Mediated Induction of Glial Fibrillary Acidic Protein: Implications for HAND.

Authors:  Lu Yang; Honghong Yao; Xufeng Chen; Yu Cai; Shannon Callen; Shilpa Buch
Journal:  Mol Neurobiol       Date:  2015-01-29       Impact factor: 5.590

4.  Interactive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood-brain barrier dysfunction: implications for HIV-1-associated neurocognitive disorder.

Authors:  Nimisha Gandhi; Zainulabedin M Saiyed; Jessica Napuri; Thangavel Samikkannu; Pichili V B Reddy; Marisela Agudelo; Pradnya Khatavkar; Shailendra K Saxena; Madhavan P N Nair
Journal:  J Neurovirol       Date:  2010-07       Impact factor: 2.643

5.  Cocaine differentially modulates chemokine production by mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients.

Authors:  M P Nair; K C Chadha; R G Hewitt; S Mahajan; A Sweet; S A Schwartz
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

6.  Increased Sensitivity to Cocaine Self-Administration in HIV-1 Transgenic Rats is Associated with Changes in Striatal Dopamine Transporter Binding.

Authors:  Scot McIntosh; Tammy Sexton; Lindsey P Pattison; Steven R Childers; Scott E Hemby
Journal:  J Neuroimmune Pharmacol       Date:  2015-03-10       Impact factor: 4.147

Review 7.  Cocaine and HIV-1 interplay: molecular mechanisms of action and addiction.

Authors:  Shilpa Buch; Honghong Yao; Minglei Guo; Tomohisa Mori; Tsung-Ping Su; John Wang
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-16       Impact factor: 4.147

Review 8.  The effects of cocaine on HIV transcription.

Authors:  Mudit Tyagi; Jaime Weber; Michael Bukrinsky; Gary L Simon
Journal:  J Neurovirol       Date:  2015-11-16       Impact factor: 2.643

9.  Cocaine-mediated enhancement of virus replication in macrophages: implications for human immunodeficiency virus-associated dementia.

Authors:  Navneet K Dhillon; Rachel Williams; Fuwang Peng; Yi-Jou Tsai; Sukhbir Dhillon; Brandon Nicolay; Milind Gadgil; Anil Kumar; Shilpa J Buch
Journal:  J Neurovirol       Date:  2007-12       Impact factor: 2.643

10.  Cannabinoid receptor-2 and HIV-associated neurocognitive disorders.

Authors:  Vishnudutt Purohit; Rao S Rapaka; Joni Rutter
Journal:  J Neuroimmune Pharmacol       Date:  2014-09       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.